Clinical trial
Meta-analysis to assess cardiovascular safety of mavacamten (CV027-1148)
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Denmark
Finland
France
Germany
Greece
Hungary
India
Israel
Italy
Japan
Korea, Democratic People's Republic of
Netherlands
Norway
Poland
Portugal
Spain
Switzerland
United Kingdom
United States
EU PAS number:
EUPAS1000000234
First published:
05/07/2024
StudyPlanned